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Abstract
Background: In epidemiological studies, subjects are often followed for a period during which study outcomes are 
measured at selected time points, such as by diagnostic testing performed on biological samples collected at each 
visit. Although test results may indicate the presence or absence of a disease or condition, they cannot provide 
information on when exactly it occurred. Such study designs generate arbitrarily censored time-to-event data, which 
can include left, interval and right censoring. Adding to this complexity, the data may be clustered such that 
observations within the same cluster are not independent, such as time to recovery of an infectious disease of family or 
community members. This data structure is observed when evaluating circumcision's effect on clearance of penile 
high risk human papillomavirus (HR-HPV) infections using data collected from the male circumcision(MC) trial 
conducted in Rakai, Uganda, where the multiple infections within individual and HPV testings performed at trial follow-
up visits gave rise to the clustered data with arbitrary censoring.
Methods: We describe the use of parametric proportional hazards frailty models and accelerated failure time frailty 
models to examine the relationship between explanatory variables and the survival outcomes that are subject to 
arbitrary censoring, while accounting for the correlation within clusters. Standard software such as SAS can be used for 
parameter estimation.
Results: Circumcision's effect on HPV infection was a secondary end point in the Rakai MC trial, and HPV genotyping 
was conducted for penile samples of a subset of trial participants collected at enrollment, 6, 12 and 24-month follow 
up visits. At enrollment, 36.7% intervention arm men (immediate circumcision) and 36.6% control arm men (delayed 
circumcision at 2 years) were infected with HR-HPV, with the number of infections per man being 1-5. The proposed 
models were used to examine whether MC facilitated clearance of the prevalent infections. Results show that clearance 
of multiple infections within each man is highly correlated, and clearance was 60% faster if a man was circumcised.
Conclusions: Parametric frailty models provide viable ways to study the relationship between exposure variables and 
clustered survival outcome that is subject to arbitrary censoring, as is often observed in HPV epidemiology studies.
Background
In epidemiological studies, subjects are often followed
over time and study outcomes are measured at selected
time points. The study outcomes may be diagnostic test-
ing results based on biological samples such as tissue,
blood, or urine samples. The testing at each time point
can detect the presence or absence of a condition (for
example, infection of an infectious disease), but it does
not provide the exact information of when the infection
or condition occurred. The best knowledge about the
actual event time is that it occurred during the interval
where discordant test results are observed at the start and
end of the interval, yielding so-called interval censoring
of time-to-event (survival) data [1]. If the event is
observed at the first follow-up, we only know that the
event occurred before the first scheduled testing time,
and this generates left censored data. On the other hand,
if a subject drops out of the study or remains event free at
the end of the study, the time to event could only be after
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the last observed testing time, which corresponds to the
well-known right censoring. When it is of interest to eval-
uate the effect of treatment on time to event occurrence,
many analysts use either the end point [2] or the mid-
point of the interval where discordant results were
observed as the actual event times. The former way intro-
duces "time aggregation" bias when estimating the hazard
rate, while the latter mid-point method reduces time-
aggregation bias under certain conditions [3]. For unbi-
ased estimation of the treatment or exposure effect,
approaches that directly model the likelihood of the arbi-
trarily censored data (including left, interval and right
censoring) can be used [4]. Other than the presence of
arbitrarily censored data, what can further complicate the
analysis is the presence of clustered data where the study
subjects are correlated within each cluster, such as
patients visiting the same clinic in a multi-site study,
members within the same family or community, or
repeated testing on the same subject. The Cox regression
model has been extended for clustered time-to-event
data to model the marginal distributions without full
specification of the correlation structure between the
clustered observations [5,6], though it has only been
established for data with non-informative right censor-
ing. For clustered data with interval censoring, [7] intro-
duces the use of conditional proportional hazards model
(i.e. semiparametric frailty model), and briefly discusses
the advantages of parametric frailty models. In this paper
we describe the use of parametric frailty models to assess
treatment or exposure effect on time to a well-defined
event for clustered survival data with arbitrary censoring,
which includes left, right, as well as interval censoring.
The model estimation can be carried out using existing
software, such as SAS (SAS Institute, Inc., Cary, NC)
PROC NLMIXED. The method is illustrated through the
application on data collected from a randomized clinical
t r i a l  o f  m a l e  c i r c u m c i s i o n  ( M C )  c o n d u c t e d  i n  R a k a i ,
Uganda, and the current study purpose is to evaluate the
effect of MC on clearance of penile high risk human pap-
illomavirus (HR-HPV) in HIV-negative men.
The following section provides a brief introduction
about the HR-HPV data to exemplify the problem of
interest. Statistical notations and the proposed model are
then presented through the context of the example.
Parameter estimation can be realized using SAS and the
SAS code for this example is provided. The analytical
r e s u l t  o n  t h e  HR - HPV  da t a  is  s u bs eq u e n t l y  p r e s e n t ed .
We conclude with discussion about the general use of the
proposed model for clustered survival data with arbitrary
censoring.
Example: Effect of Male Circumcision on HR-HPV clearance
A clinical trial of MC was conducted on initially HIV-
negative uncircumcised men aged 15-49 years in Rakai
District of Uganda during 2003-2006 [8,9]. Approxi-
mately 5000 men were enrolled in the trial and random-
ized to either immediate circumcision (intervention arm)
or delayed circumcision after 24 months (control arm). At
enrollment and follow-ups scheduled at 6, 12, and 24
months, variables about participant sociodemographic
characteristics, sexual risk behaviors and symptoms of
sexually transmitted infections were recorded using ques-
tionnaires. Penile swabs were collected by clinicians from
the preputial cavity of uncircumcised men and from the
coronal sulcus/glans of circumcised men. Circumcision
effect on HPV was a secondary endpoint in the trial and
HPV testing was performed restricted to consistently
HIV-negative married men with concurrently enrollment
wives. HPV testing was performed on samples collected
at all four visits only for a subset of randomly selected 330
such men (39.5%) in the intervention arm and 314 men
(39.1%) in the control arm due to resource limitation.
Roche HPV Linear Array (Roche Diagnostics, Indianapo-
lis, IN) was used for HPV genotyping. The fourteen geno-
types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and
68 were considered HR-HPV, that is, carcinogenic viral
genotypes. Therefore, for each participant at each visit,
there are fourteen binary indicators indicating the pres-
ence or absence of the fourteen HR-HPV genotypes,
respectively. At enrollment, the intervention and control
arm were comparable in sociodemographic and sexual
behavioral characteristics [10]; the prevalence of HR-
HPV was also comparable, with 36.7% men being positive
on at least one HR-HPV genotype in the intervention arm
and 36.6% in the control arm. One particular interest
with this dataset is to study whether MC facilitates HR-
HPV clearance process since foreskin provides a reser-
voire for viral protein expression. We studied circumci-
sion's effect on clearance of enrollment prevalent HR-
HPV infections, and the prevalent infection profile is
summarized in Table 1 (upper panel).
Clustered data structure arises in this dataset, as each
participant (a cluster) had testing results for the fourteen
HR-HPV genotypes. A person with multiple infections
may contribute multiple events (i.e. clearances) that are
likely to be highly correlated. The exact clearance time
point is unavailable, but it is known to be either before
the first subsequent visit (left censored), or lie within an
interval between two visits (interval censored), or after
the last follow-up visit (right-censored).
Methods
Notations
Let T denote the random variable for the time to event.
Assume there are n clusters in the study, and the ith clus-
ter (i = 1, 2, , n) has j = 1, 2, , ni observations. In the
HR-HPV example, T is the time to clearance of an HR-
HPV infection, and each participant is a cluster. For aKong et al. BMC Medical Research Methodology 2010, 10:40
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person with single genotype HR-HPV infection, ni = 1;
while if a person has multiple HR-HPV genotype infec-
tions, ni > 1, and the clearance of these multiple infections
is not independent. For the jth HR-HPV genotype infec-
tion (j = 1, 2, , ni) on the ith participant, tij is the actual
clearance time which is not exactly observed. Let (aij, bij]
denote the interval where the clearance occurs, i.e. aij <tij
≤ bij. If a prevalent infection of genotype j for person i is
observed to be cleared at first follow-up, then aij = 0, and
tij ≤ bij = 6 months, which corresponds to a left censored
observation; if it is never cleared during the trial period,
then aij = 24 months (the last follow-up time), and aij <tij <
∞ (the upper bound bij can be viewed as ∞), which is a
right censored observation.
Suppose there are p explanatory variables, which can
include the variable indicating treatment arm and other
covariates that may be of interest, and let xij denote the
vector of explanatory variables for the jth infection in
person i. Without loss of generality, we only consider one
explanatory variable for treatment arm, and xij  = 1
denotes intervention and xij = 0 denotes control. Note
that treatment arm for the fourteen HR-HPV genotypes
is identical for each participant, although in general
applications, xij can be different for different observations
belonging to the same cluster.
Parametric Proportional Hazards Frailty Model
Let  h(t) denote the hazard function representing the
"hazard" (i.e. the instantaneous rate) of clearance at time
t. To examine the treatment effect on clearance, we can
model the hazard to be a function of the explanatory vari-
ables, while at the same time including a random effect to
account for the correlation between the multiple HR-
HPV genotype infections on such infected participants.
For example, as in [7], for clearance of the jth infection on
person i, we can use the conditional proportional hazards
model (or semiparametric frailty model):
Without the ξi term, expression 1 is just the ordinary
Cox proportional hazards model, where hij(t;x) is the
"hazard" for clearance of the jth genotype infection in
person i, h0(t) is the baseline hazard for a person with all
explanatory variables being zero. The ξi term in expres-
sion 1 represents a random effect realized on the ith per-
son. It is assumed to follow a prior distribution, such as a
normal distribution, or equivalently exp(ξi) ~ a log-nor-
mal distribution. The use of the normal random effect ξi
on t (through the hazard function) is one way of introduc-
ing correlation within the ith cluster, and is similar to that
in linear mixed effects or generalized linear mixed effects
models. Because the same realization value of ξi (from its
prior distribution) is shared by observations on the multi-
ple HR-HPV genotype infections within the ith person
(thus its' subscript does not depend on j which indexes
genotype), it is therefore taken into account of the depen-
dence between the clearance times of these multiple HR-
HPV infections. One advantage of using normally distrib-
uted random effect is that more complicated correlation
structures between observations, such as multi-level cor-
relations, can be handled naturally by extending the use
of a univariate normal random effect to multivariate nor-
mal random effects [11,12].
Direct estimation of the coefficient parameters from
model 1 by maximizing the likelihood may not be avail-
able with standard software such as SAS. To reduce the
computation complexity, we further assume a parametric
form on the clearance time for participants in the control
ht ht x j n i n ij ij i i ( ; ) ( )exp( ), , , , , , . x = ′ += = 0 12 12 bx for   and  
Table 1: Enrollment prevalence of HR-HPV infections and observed clearance proportions in the intervention arm (I) and 
the control arm (C).
Intervention
n = 330 (%)
Control
n = 314 (%)
Prevalence
Rate Ratio (I/C)
95% Confidence
Interval
No. of men infected
with Any HR-HPV
121 (36.7) 115 (36.6) 1.00 (0.82-1.23)
Single HR-HPV 77 (23.3) 80 (25.5) 0.92 (0.70-1.20)
Multiple HR-HPVs 44 (13.3) 35 (11.1) 1.20 (0.79-1.81)
Total No. of infections
No. of infections
cleared
180 169
by 6-month 112 (62.2) 98 (58.0)
by 12-month 141 (78.3) 123 (72.8)
by 24-month 171 (95.0) 161 (95.3)Kong et al. BMC Medical Research Methodology 2010, 10:40
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arm, for example, conditional on the random effect  ξfor a
person in the control arm, let time to clearance of any
HR-HPV infection have a Weibull distribution. That is
h0(t) = γα0tγ-1, where γ(γ > 0) and α0 are the shape and
scale parameters respectively for the Weibull distribu-
tion. The hazard function for Weibull distribution is a
monotone function of t [13] (Figure 1a). The Gompertz
distribution introduced for describing human mortality
[4] is another parameteric distribution that has the pro-
portional hazards property, and can be considered in the
proportional hazards frailty model 1 .
Plugging h0(t) into expression 1, for the jth HR-HPV
infection in person i with explanatory variables xij, j = 1,
2, , ni, i = 1, 2, , n, the Weibull frailty model for clear-
ance is:
where the random frailty effect is assumed to follow a
normal distribution with zero mean (i.e. exp (ξi) ~log-
normal distribution). Model 2 implies that conditional on
the random frailty ξi, the clearance of any HR-HPV infec-
tion follows a Weibull distribution with shape parameter
γ and scale parameter  , where
circumcision's effect on clearance is quantified by its'
coefficient parameter β. ξi is the random effect shared by
the multiple infections within the same person. Given a
value of ξi, the hazard ratio of HR-HPV clearance
between the intervention and control arm is exp (β).
Therefore, if β estimated from the data is significantly
larger than 0, then exp(β) > 1, indicating the instanta-
neous clearance rate is larger if a participant was circum-
cised than not circumcised.
Parametric Accelerated Failure Time Frailty Model
The Weibull frailty model given in 2 can be equivalently
expressed in terms of the survivor function of the Weibull
distribution as:
ht t
x
ij ij
ij ij i i
(; )
exp( ) ~ (
x =
=+ ′ +
− ga
ab b x x
g 1
0 where   and  Normal 0 0
2 ,) . s
ab b x ij ij i x =+ ′ + exp( ) 0
St t ij i ij (; ) e x p ( ) x |xa
g =− (3)
Figure 1 Plot of Weibull and Log-logisitc hazard functions. (a): Conditional hazard functions of the Weibull model and Log-logisitic model based 
on estimated parameter values for the intervention arm (I) and control arm (C). The Weibull hazard function is a monotonically decreasing function, 
whereas the log-logistic hazard funtion is a unimodal function that may better describe the natural history of HPV. (b): Conditional hazard ratio be-
tween the intervention and control arms from the two models. The Weibull model imposes a constant ratio, whereas the log-logistic model allows 
the clearance rate ratio to change over time.Kong et al. BMC Medical Research Methodology 2010, 10:40
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where S0(t) is the baseline survivor function of the con-
ditional Weibull distribution, that is, S0(t) = exp(-α0tγ),
where  α0  = exp(β0). Thus we have
.
Therefore, for a specific participant, the clearance pro-
cess for an uncircumcised man is eβ times of the clearance
process if the man was circumcised, implying circumci-
sion accelerates HR-HPV clearance with a factor of
exp( β).
Conditional on the random effect, expression 4 corre-
sponding to Weibull distribution in fact belongs to the
family of parametric accelerated failure time (AFT) mod-
els [4]. For clustered survival data, the general AFT model
with normal random frailty effect can be written as:
where ξi ~Normal (0, σ2), S0(·) is the baseline survivor
function of a parametric survival distribution, such as
Weibull distribution, log-normal distribution, general-
ized gamma distribution, log-logistic distribution, gener-
alized  F  distribution [13], and inverse Gaussian
distribution [4]. Compared to parametric proportional
hazards models where only few distributions have the
proportional hazard property, this family of models com-
prehends a broader class of parametric survival distribu-
tions and allows for more flexibility on the shape of the
conditional hazard function. It can be shown that AFT
models can be expressed in log-linear model form [4],
where it is easy to see that the predictor variables act
additively on the logarithm of the survival time T, or
equivalently multiplicatively on T itself. Conditional on a
given value of the frailty effect ξi in the AFT model 5, exp
(β) has the interpretation of the ratio of the median (or
any percentile) survival times between intervention and
control arms. Moreover, Additional file 1 shows that the
AFT frailty model also provides a marginal interpretation
of the treatment effect, where -β is the average log ratio of
the clearance times between intervention and control
arms, i.e.  .
It is important to notice that, however, except for the
Weibull distribution (including the exponential distribu-
tion), other aforementioned distributions for AFT frailty
models do not have the proportional hazards property
and thus cannot be modeled as a proportional hazards
frailty model given in 1, exp (β) consequently does not
have the interpretation of conditional hazard ratio.
For the HR-HPV data, the proportional hazard frailty
model 2 with Weibull distribution assumption implicitly
imposes a constant instant clearance rate ratio (condi-
tional on the random effect) over time between interven-
tion arm and control arm (Figure 1b). The clearance rate
ratio may however change over time. From Table 1, the
majority of infections had cleared by year 2 in either arm,
thus the clearance rate ratio should be close to 1; whereas
the rate ratio by month 6 may be different from 1. The
log-logistic distribution was also fit for the survivor func-
tion S(t|ξi) in the AFT frailty model 5. The hazard of log-
logistic distribution is a unimodal function of t when its
shape parameter is larger than 1 (Figure 1a), which may
better capture the natural history of HPV infection. It
also allows the clearance rate ratio between arms to
change over time(Figure 1b). The log-logistic AFT ran-
dom frailty model is:
where aij = exp(β0 + xij β + ξi), and ξi ~Normal (0, σ2).
Estimation of model parameters
With parametric assumptions in model 1 or model 5,
parameters (including fixed effects β and the variance of
the random effect σ2) can be estimated using the maxi-
mum likelihood method. Recall that for the jth infection
in the ith participant, the clearance time is observed to be
in the interval of (aij, bij], where aij = 0 for left censored
observations and bij = ∞ for right censored observations.
For the ni genotype HR-HPV infections in person i, their
clearances can either be left, right, or interval censored.
Without loss of generality, let li denote the number of left
censored observations and ri denote the number of right
censored observations, and hence ni -li -ri is the number
of interval censored observations on person i. Thus the
full likelihood on all participants can be written as:
= ′ +⋅
⎛
⎝
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where Sij(t|ξi) is the conditional survivor function for
the jth observation in person i, and given ξi, the condi-
tional survivor functions corresponding to the multiple
infections within person i  are independent.
 is the density function for
the normal random effect ξi. The full likelihood is then
obtained by integrating over all the possible values of the
random effect.
The maximum likelihood estimate (MLE), denoted as
 and  , can be attained by maximizing the likelihood
in expression 7 using iterative procedures, and the vari-
ance-covariance matrix is estimated as the inverse Hes-
sian matrix. To test the significance of the explanatory
variable, i.e. H0 : βk = 0, the likelihood ratio (LR) statistic
(difference in -2Log(L) between the hierarchical models
containing and not containing the variable) can be used
by comparing it to a χ2 distribution with 1 degree of free-
dom [14]. Alternatively, Wald type inference can be
drawn with its MLE and variance. For the random effect
parameter σ2, the null hypothesis H0: σ2 = 0 corresponds
to the situation where all of the observations within a
cluster are independent, and thus may be of interest of
testing. However, since σ2 ≥ 0,   = 0 is the boundary of
the parameter space of σ2. [15] showed that the asymp-
totic distribution of the LR statistic (comparing between
the models containing and not containing the random
effect) is a 50:50 mixture of the   and   distribution.
Thus a simple rule of computing P-value for testing H0: σ2
= 0 is that if the LR statistic is 0, then P = 1; otherwise, the
P-value is half of the P-value obtained from comparing
the LR statistic to   distribution [16].
Since we assume a normal prior on the random frailty
effect, the likelihood function normally does not have a
close analytical form, although SAS PROC NLMIXED
can numerically compute the integrals and maximize the
approximated likelihood. The procedure provides com-
monly estimated statistics such as the MLE, Wald-type
confidence intervals, and -2log-likelihood. In order to
perform likelihood ratio inference for a variable, the hier-
archical models with and without the variable have to be
estimated respectively. The SAS code for analyzing the
HR-HPV clearance data using model 2 is listed in Addi-
tional file 2 as an illustration, and relevant computation
details are also discussed. The format of the input dataset
and some useful options needed when calling the proce-
dure are also described.
Results of Study on Male Circumcision Effect on HR-
HPV Clearance
Table 1 (upper panel) shows the enrollment prevalent
infection profile for the intervention and the control
arms. The number of HR-HPV infections (genotypes) per
participant ranges from 1 to 5, indicating cluster size ni ￿
[1,5]. The proportion of prevalent infections cleared by
each follow-up visit is summarized in the bottom panel of
Table 1. By the 6-month visit, 62.2% had cleared in the
intervention arm and 58.0% had cleared in the control
arm. At the end of the trial (24-month), the majority of
the infections had cleared in both arms. It is of interest to
see whether clearance was faster in the circumcised men.
To estimate the effect of circumcision on HR-HPV clear-
ance, the Weibull frailty model 4 and log-logistic AFT
frailty model 6 were applied respectively, and the model
parameters were estimated by maximizing the full likeli-
hood given in equation 7. Table 2 lists the parameter esti-
mates from the Weibull frailty model (left panel) and Log-
l o g i s t i c  f r a i l t y  m o d e l  ( r i g h t  p a n e l )  o b t a i n e d  b y  P R O C
NLMIXED. The variance estimate for the random effect
ξi from the Weibull model is   = 0.88, and the likeli-
hood ratio test on H0: σ2 = 0 yields P-value < 0.0001. The
corresponding estimate from the Log-logistic model is
 = 0.85 (P = 0.002). Therefore, the clearance of multi-
ple infections on the same individual is significantly cor-
related. Not accounting for the correlation will
underestimate the standard error of the treatment effect
estimate. The primary interest (circumcision's effect) is
reflected by β1, and the two models yield very similar
results. Although the shape of the conditional hazard
f i
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functions from the two models is different (monotoni-
cally decreasing for the Weibull distribution and uni-
modal for the log-logistic distribution, Figure 1, the
parameter estimates of interest from the two different
models are highly comparable. From either model,   >
0 and the one-sided P-value = 0.02. Therefore, for each
man, circumcision could significantly facilitate HR-HPV
clearance should the man undergo circumcision. The
median clearance time ratio is about 1.6 (95% CI, 0.9-2.2),
implying clearance would be about 60% faster if a man
was circumcised. HPV infection starts in epidermal basal
cells and the virus then moves to epithelial surface [17],
thus removal of foreskin physically removes a reservoire
for viral replication, which may be one reason for the
faster clearance.
There are several limitations of this application, how-
ever. One is that it was found that at the follow-up visits, a
significant higher proportion of samples collected on cir-
cumcised men could not be amplified rendering more
missing HPV results in intervention arm. In this illustra-
tion, it was assumed that the infection persisted during
the interval if the testing result was missing for the fol-
low-up visit at the end of the interval. This may underes-
timate circumcision's effect. Techniques for dealing with
missing data, such as multiple imputation [18,19], can be
utilized for this specific dataset. Another limitation for
this study is that the follow-up intervals of 6, 12 and 24
months were too long to capture the clearance of HPV
infection. It has been known that the median duration of
genital HPV infection in woman is 8 months, and persis-
tent detectable infection rate is approximately 30% after 1
year and 9% after 2 years [17]. In a recent observational
study on men [20], it is reported that the median time to
clearance was 5.9 months (95% CI, 5.7-6.1 months), and
75% infections had cleared by 24 months after initial
detection, implying the clearance rate is low when t is
large. With the effective immune response to HPV, most
infections had cleared by 6 months as observed in the
trial participants, meaning that there are no data describ-
ing the early phase of the clearance process. The limited
data determine that there is "little to choose between
alternative distributional models" [4] and different mod-
els may yield similar results in the range where data are
observed. It is suggested to adopt the model "most conve-
nient for the purpose in hand " [4]. However, any extrapo-
lation on the functional form of the clearance process
from the estimated model should be conducted with cau-
tion. This trial was primarily designed to study male cir-
cumcision's effect on preventing HIV acquisition. If it is
of interest to examine HPV clearance in a future study,
the study design should allow for a more frequent testing
b
∧
1
Table 2: Parameter estimates from the Weibull and Log-logistic frailty model with normal random effect for studying 
circumcision's effect on HR-HPV clearance.
Weibull Log-logistic
Est. Std. Err. 95% C.I. LR P-
value 
(2-sided)
Est. Std. Err. 95% C.I. LR P-
value 
(2-sided)
0.96 0.16 (0.63, 1.28) 1.78 0.28 (1.23, 2.33)
-1.59 0.34 (-2.25, -0.93) < 0.0001 -1.30 0.17 (-1.63, -0.96) < 0.0001
0.42 0.23 (-0.02, 0.87) 0.04 0.45 0.22 (0.02, 0.89) 0.03
MSR2 1.56 0.35 (0.87, 2.24) 1.57 0.34 (0.90, 2.24)
The P-values were all obtained using likelihood ratio (LR) test.
1γ is a nuisance parameter, thus no P-value is presented as no hypothesis testing was performed. 2MSR: median survival time ratio (conditional 
on the random effect).
0Weibull model: MSR = exp( β1); Log-logistic model: MSR = exp(β1).
g
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interval in order to capture the whole process. The pre-
sented parametric frailty models implicitly assume the
same conditional baseline hazard functions for the clear-
ance of different genotype infections within an individual.
The different genotypes all belong to the papillomavirus
family, and the mechanism of immune response is the
same when fighting against the different type of HPV
infections. Therefore it is reasonable to apply the same
form of conditional baseline hazard functions for the
clearance of different genotype infections.
Conclusion and Discussion
Arbitrarily censored survival data is not uncommon in
epidemiological studies, and the censoring nature should
be considered during analysis to reduce estimation bias,
or when the disease onset and diagnosis are two steps
that need to be differentiated [7]. Moreover, clustered
data may arise and the correlation within each cluster
should also be accounted for. In the current study we par-
ticularly describe the use of parametric frailty models to
explore treatment effect's on survival when data are clus-
tered and subject to arbitrary censoring. The two main
classes of models are parametric proportional hazards
frailty model and accelerated failure time frailty model.
Most commonly used survival distributions can be used
in these models, providing abundant choices of paramet-
ric forms to appropriately model the data of interest. For
example, Weibull distribution and Gamma distribution
can be used for survival problems where the hazard
monotonically changes with time, and log-logistic and
log-normal distribution can be used when the hazard is a
unimodal function of time. The main advantage of adopt-
ing a parametric form is for computational ease. On the
other hand, with the presence of arbitrary censoring and
clustering, it is difficult to perform model diagnostics on
the assumption of the parametric form. A clear under-
standing of the scientific nature of the problem to be
addressed is essential for choosing an appropriate para-
metric distribution in analysis. When using normal ran-
dom effect, the presented models can be estimated using
SAS PROC NLIMIXED, and the code for analyzing the
example HPV dataset is provided in the Additional file 2.
Models with random effects following other distributions
may be estimated using PROC NLIMIXED by transform-
ing the normal random effect using appropriate probabil-
ity transformation function provided by SAS [21,22].
Alternatively, for gamma frailty model or log-t propor-
tional hazards frailty model for data with arbitrary cen-
soring, the "frailty()" function provided in the R package
"survival" can be used.
Genital HPV infection has high prevalence in both men
and women, and the high risk types of HPV are well
known t o be  as socia t ed wit h a nog e nita l ca nc e rs,  espe -
cially cervical cancer [17]. Current diagnostic tools allow
for simultaneous detection of multiple HPV genotypes,
though the actual infection or clearance time is unknown.
Therefore clustered data with arbitrary censoring are
normally generated from such studies. The presented
modeling approach can be used to study factors associ-
ated with HPV clearance (or persistence), or to compare
the clearance process between different genotypes to
examine type-specific persistence. However, as pointed
earlier, the design for such studies need to allow for
appropriate short testing intervals to capture the entire
process.
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